A US pharmaceutical company has asked an ICC emergency arbitrator to halt its Taiwanese partner’s development of a drug to treat a rare neuromuscular disease – a dispute arising from a US$250 million licensing deal.
06 March 2025
An ICC tribunal has issued a partial award in a second arbitration between a Taiwanese pharmaceutical company and its Austrian partner over a blood cancer treatment – a case where the parties had been seeking US$5 billion.
17 February 2025
A US court has restrained a Taiwanese electronics group from pursuing CIETAC arbitration against a Massachusetts-based developer of power converters used in network servers.
02 July 2024
A Taiwan-based manufacturer of flash memory controllers has said it will bring a SIAC claim against a US chipmaker for pulling out of a US$3.8 billion merger.
16 August 2023
A Chilean-Taiwanese mining venture is reportedly considering a US$2.5 billion treaty claim against Chile, alleging that plans to give a state-owned entity exclusive rights over a lithium deposit amount to an unlawful expropriation.
25 November 2022
A US court has partially enforced an ICC award won by an Austrian pharmaceuticals company against its Taiwanese partner after a €142 million order for damages was set aside in Germany.
22 March 2022
The German Supreme Court has set aside a €140 million damages award against a Taiwanese pharmaceuticals company after finding the ICC tribunal violated its right to be heard – in a fight over a blood cancer drug that has spawned a second ICC case worth US$5 billion and a criminal complaint.
16 February 2022
An Austrian pharmaceuticals company has asked a US court to grant discovery to support criminal allegations that its Taiwanese partner has made fraudulent statements in two ICC arbitrations arising from a multibillion-euro dispute over a blood cancer drug.
20 January 2022
17 January 2018
Japanese electronics company Sharp has asked a US court to block a SIAC emergency arbitrator's confidentiality order prohibiting public discussion of an arbitration with a Chinese licensee - which it says breaches its right to free speech under the US Constitution.
16 August 2017
Unlock unlimited access to all Global Arbitration Review content